UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050028
Receipt number R000056993
Scientific Title Endoscopic cutting internalization versus removal of the endoscopic transpapillary nasogallbladder drainage tube in preoperative management of acute cholecystitis: a retrospective multicenter cohort study
Date of disclosure of the study information 2023/02/01
Last modified on 2023/01/13 14:44:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Endoscopic cutting internalization versus removal of the endoscopic transpapillary nasogallbladder drainage tube in preoperative management of acute cholecystitis: a retrospective multicenter cohort study

Acronym

Endoscopic cutting internalization versus removal of the endoscopic transpapillary nasogallbladder drainage tube

Scientific Title

Endoscopic cutting internalization versus removal of the endoscopic transpapillary nasogallbladder drainage tube in preoperative management of acute cholecystitis: a retrospective multicenter cohort study

Scientific Title:Acronym

Endoscopic cutting internalization versus removal of the endoscopic transpapillary nasogallbladder drainage tube

Region

Japan


Condition

Condition

Acute cholecystitis

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the late adverse event, such as recurrence rate of cholecystitis, between the converting from ENGBD to EGBS and removing ENGBD after improvement of cholecystitis.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To compare the late adverse events while waiting for elective cholecystectomy between the Cutting and the Removal groups.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

1) Patient who underwent ENGBD for management of acute cholecystitis
2) Patient who underwent elective cholecystectomy.

Key exclusion criteria

1) direct cholecystectomy with in-situ ENGBD
2) prior history of upper gastrointestinal or biliary tract surgery, except for gastrectomy with Billroth I reconstruction
3) presence of upper gastrointestinal or pancreatobiliary malignancies
4) presence of bile duct stricture, including primary sclerosing cholangitis.

Target sample size

70


Research contact person

Name of lead principal investigator

1st name Akinori
Middle name
Last name Maruta

Organization

Gifu Prefectural General Medical Center

Division name

Department of Gastroenterology

Zip code

500-8717

Address

4-6-1 Noisshiki, Gifu City, Gifu Prefecture

TEL

058-246-1111

Email

mrak5844@yahoo.co.jp


Public contact

Name of contact person

1st name Akinori
Middle name
Last name Maruta

Organization

Gifu Prefectural General Medical Center

Division name

Department of Gastroenterology

Zip code

500-8717

Address

4-6-1 Noisshiki, Gifu City, Gifu Prefecture

TEL

058-246-1111

Homepage URL


Email

mrak5844@yahoo.co.jp


Sponsor or person

Institute

Gifu Prefectural General Medical Center

Institute

Department

Personal name



Funding Source

Organization

Gifu Prefectural General Medical Center

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gifu Prefectural General Medical Center

Address

4-6-1 Noisshiki, Gifu City, Gifu Prefecture

Tel

058-246-1111

Email

mrak5844@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

96

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 01 Month 13 Day

Date of IRB

2023 Year 02 Month 01 Day

Anticipated trial start date

2023 Year 01 Month 13 Day

Last follow-up date

2023 Year 02 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The study was closed because it was a retrospective observational study.


Management information

Registered date

2023 Year 01 Month 13 Day

Last modified on

2023 Year 01 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056993


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name